| Year |
Citation |
Score |
| 2009 |
Eggler AL, Small E, Hannink M, Mesecar AD. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. The Biochemical Journal. 422: 171-80. PMID 19489739 DOI: 10.1042/Bj20090471 |
0.415 |
|
| 2008 |
Westfall SD, Sachdev S, Das P, Hearne LB, Hannink M, Roberts RM, Ezashi T. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells and Development. 17: 869-81. PMID 18811242 DOI: 10.1089/Scd.2007.0240 |
0.304 |
|
| 2008 |
Lo SC, Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Experimental Cell Research. 314: 1789-803. PMID 18387606 DOI: 10.1016/J.Yexcr.2008.02.014 |
0.407 |
|
| 2007 |
Zhou W, Lo SC, Liu JH, Hannink M, Lubahn DB. ERRbeta: a potent inhibitor of Nrf2 transcriptional activity. Molecular and Cellular Endocrinology. 278: 52-62. PMID 17920186 DOI: 10.1016/J.Mce.2007.08.011 |
0.307 |
|
| 2007 |
Liu XM, Peyton KJ, Ensenat D, Wang H, Hannink M, Alam J, Durante W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovascular Research. 75: 381-9. PMID 17408602 DOI: 10.1016/J.Cardiores.2007.03.004 |
0.324 |
|
| 2006 |
Lo SC, Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. The Journal of Biological Chemistry. 281: 37893-903. PMID 17046835 DOI: 10.1074/Jbc.M606539200 |
0.37 |
|
| 2006 |
Lo SC, Li X, Henzl MT, Beamer LJ, Hannink M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. The Embo Journal. 25: 3605-17. PMID 16888629 DOI: 10.1038/Sj.Emboj.7601243 |
0.373 |
|
| 2006 |
Lo SC, Hannink M. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1. Molecular and Cellular Biology. 26: 1235-44. PMID 16449638 DOI: 10.1128/Mcb.26.4.1235-1244.2006 |
0.369 |
|
| 2005 |
Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. The Journal of Biological Chemistry. 280: 30091-9. PMID 15983046 DOI: 10.1074/Jbc.M501279200 |
0.373 |
|
| 2004 |
Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Molecular and Cellular Biology. 24: 10941-53. PMID 15572695 DOI: 10.1128/Mcb.24.24.10941-10953.2004 |
0.357 |
|
| 2004 |
Li X, Zhang D, Hannink M, Beamer LJ. Crystal structure of the Kelch domain of human Keap1. The Journal of Biological Chemistry. 279: 54750-8. PMID 15475350 DOI: 10.1074/Jbc.M410073200 |
0.347 |
|
| 2003 |
Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Molecular and Cellular Biology. 23: 8137-51. PMID 14585973 DOI: 10.1128/Mcb.23.22.8137-8151.2003 |
0.333 |
|
| 2003 |
Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Molecular and Cellular Biology. 23: 7198-209. PMID 14517290 DOI: 10.1128/Mcb.23.20.7198-7209.2003 |
0.355 |
|
| 2001 |
Richter CA, Tillitt DE, Hannink M. Regulation of subcellular localization of the aryl hydrocarbon receptor (AhR). Archives of Biochemistry and Biophysics. 389: 207-17. PMID 11339810 DOI: 10.1006/Abbi.2001.2339 |
0.494 |
|
| 2001 |
Lee SH, Hannink M. The N-terminal Nuclear Export Sequence of IκBα Is Required for RanGTP-dependent Binding to CRM1 Journal of Biological Chemistry. 276: 23599-23606. PMID 11319224 DOI: 10.1074/Jbc.M011197200 |
0.406 |
|
| 1997 |
Sachdev S, Diehl JA, McKinsey TA, Hans A, Hannink M. A threshold nuclear level of the v-Rel oncoprotein is required for transformation of avian lymphocytes. Oncogene. 14: 2585-94. PMID 9191058 DOI: 10.1038/sj.onc.1201108 |
0.311 |
|
| 1997 |
Sachdev S, Hannink M. The ankyrin repeat domain of I KB a mediates nuclear shuttling reduced control by iicb-a over nuclear localization of rel proteins contributes to oncogenic activation Faseb Journal. 11. |
0.349 |
|
| 1996 |
Leanna CA, Hannink M. The reverse two-hybrid system: A genetic scheme for selection against specific protein/protein interactions Nucleic Acids Research. 24: 3341-3347. PMID 8811088 DOI: 10.1093/Nar/24.17.3341 |
0.369 |
|
| 1996 |
Rottjakob EM, Sachdev S, Leanna CA, McKinsey TA, Hannink M. PEST-dependent cytoplasmic retention of v-Rel by IκB-α: Evidence that IκB-α regulates cellular localization of c-Rel and v-Rel by distinct mechanisms Journal of Virology. 70: 3176-3188. PMID 8627798 DOI: 10.1128/Jvi.70.5.3176-3188.1996 |
0.376 |
|
| 1994 |
Diehl JA, Hannink M. Identification of a C/EBP-Rel complex in avian lymphoid cells Molecular and Cellular Biology. 14: 6635-6646. PMID 7935382 DOI: 10.1128/Mcb.14.10.6635 |
0.393 |
|
| 1993 |
Diehl JA, Mckinsey TA, Hannink M. Differential pp40IκB-β inhibition of DNA binding by rel proteins Molecular and Cellular Biology. 13: 1769-1778. PMID 8441412 DOI: 10.1128/Mcb.13.3.1769 |
0.358 |
|
| 1993 |
Diehl JA, Hannink M. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel Journal of Virology. 67: 7161-7171. PMID 8230438 |
0.322 |
|
| 1992 |
Walker WH, Stein B, Ganchi PA, Hoffman JA, Kaufman PA, Ballard DW, Hannink M, Greene WC. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation. Journal of Virology. 66: 5018-29. PMID 1321284 DOI: 10.1128/Jvi.66.8.5018-5029.1992 |
0.462 |
|
| 1991 |
Hannink M, Temin HM. Molecular mechanisms of transformation by the v-rel oncogene. Critical Reviews in Oncogenesis. 2: 293-309. PMID 1958712 |
0.326 |
|
| 1990 |
Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M, Greene WC. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function Cell. 63: 803-814. PMID 2225078 DOI: 10.1016/0092-8674(90)90146-6 |
0.371 |
|
| 1989 |
Hannink M, Temin HM. Transactivation of gene expression by nuclear and cytoplasmic rel proteins Molecular and Cellular Biology. 9: 4323-4336. PMID 2555689 DOI: 10.1128/Mcb.9.10.4323 |
0.482 |
|
| 1989 |
Hannink M, Donoghue DJ. Structure and function of platelet-derived growth factor (PDGF) and related proteins Bba - Reviews On Cancer. 989: 1-10. PMID 2546599 DOI: 10.1016/0304-419X(89)90031-0 |
0.525 |
|
| 1988 |
Singh B, Wittenberg C, Hannink M, Reed SI, Donoghue DJ, Arlinghaus RB. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity. Virology. 164: 114-20. PMID 2966489 DOI: 10.1016/0042-6822(88)90626-5 |
0.612 |
|
| 1988 |
Hannink M, Donoghue DJ. Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface Journal of Cell Biology. 107: 287-298. PMID 2455725 DOI: 10.1083/Jcb.107.1.287 |
0.59 |
|
| 1987 |
Lee BA, Maher DW, Hannink M, Donoghue DJ. Identification of a signal for nuclear targeting in platelet-derived-growth-factor-related molecules Molecular and Cellular Biology. 7: 3527-3537. PMID 3316980 DOI: 10.1128/Mcb.7.10.3527 |
0.664 |
|
| 1986 |
Hannink M, Sauer MK, Donoghue DJ. Deletions in the C-terminal coding region of the v-sis gene: Dimerization is required for transformation Molecular and Cellular Biology. 6: 1304-1314. PMID 3785165 DOI: 10.1128/Mcb.6.4.1304 |
0.633 |
|
| 1986 |
Hannink M, Donoghue DJ. Biosynthesis of the v-sis gene product: Signal sequence cleavage, glycosylation, and proteolytic processing Molecular and Cellular Biology. 6: 1343-1348. PMID 3537701 DOI: 10.1128/Mcb.6.4.1343 |
0.638 |
|
| 1986 |
Hannink M, Donoghue DJ. Cell surface expression of membrane-anchored v-sis gene products: Glycosylation is not required for cell surface transport Journal of Cell Biology. 103: 2311-2322. PMID 3536965 DOI: 10.1083/Jcb.103.6.2311 |
0.624 |
|
| 1986 |
Sauer MK, Hannink M, Donoghue DJ. Deletions in the N-terminal coding region of the v-sis gene: Determination of the minimal transforming region Journal of Virology. 59: 292-300. PMID 3525855 DOI: 10.1128/Jvi.59.2.292-300.1986 |
0.631 |
|
| 1986 |
Singh B, Hannink M, Donoghue DJ, Arlinghaus RB. p37(mos)-Associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos Journal of Virology. 60: 1148-1152. PMID 3023666 DOI: 10.1128/Jvi.60.3.1148-1152.1986 |
0.439 |
|
| 1986 |
Bold RJ, Hannink M, Donoghue DJ. Functions of the mos oncogene family and associated gene products Cancer Surveys. 5: 243-255. PMID 2946405 |
0.368 |
|
| 1986 |
Singh B, Hannink M, Donoghue DJ, Arlinghaus RB. p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. Journal of Virology. 60: 1148-1152. DOI: 10.1128/jvi.60.3.1148-1152.1986 |
0.541 |
|
| 1985 |
Hannink M, Donoghue DJ. Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation Proceedings of the National Academy of Sciences of the United States of America. 82: 7894-7898. PMID 2999782 DOI: 10.1073/Pnas.82.23.7894 |
0.611 |
|
| 1984 |
Hannink M, Donoghue DJ. Requirement for a signal sequence in biological expression of the v-sis oncogene Science. 226: 1197-1199. PMID 6095451 DOI: 10.1126/Science.6095451 |
0.597 |
|
| Show low-probability matches. |
